Novel targets/compounds for the treatment of Bronchopulmonary Dysplasia (BPD) - Biowebspin | Biowebspin
Logo Biowebspin

Biowebspin : THE #1 ACADEMIA-INDUSTRY PARTNERING NETWORK IN LIFE SCIENCES

The worldwide platform to find industrial partners and funding

External open innovation partner programNovel targets/compounds for the treatment of Bronchopulmonary Dysplasia (BPD)

Have you identified new targets/compounds for the treatment of Bronchopulmonary Dysplasia? Are you interested in partnering with a pharma company to translate your new science into a new medicine?

What we are looking for
We are looking for novel targets/compounds for the treatment of Bronchopulmonary Dysplasia (BPD).
We are not interested in the following compounds: corticosteroids, vitamin A and D, caffeine, phosphodiesterase inhibitors, interleukin 1 receptor antagonists.
The target/compound must not have IP already present, must not be fully published/disclosed.

What we offer & How does it work
All proposals will be assessed by our Research and Development team. Based on the level of interest within the Company research portfolio and strategic fit, we will enter into discussion with selected candidate(s), potentially leading to partnership agreements or collaborations.

Proponents that submit proposals of interest will be contacted within 8 weeks of submission to clarify additional details.

What to submit

Submit a proposal in a form which is available online (it takes about 15 minutes). The proposal should be brief with enough background to understand its innovativeness. Aims should be clearly stated. The proposal should have a strong rationale and the future steps to develop the project should be well detailed and explained. The applicant should also provide information about his or her critical knowledge that is applicable for the project, and how the knowledge could be supplemented (i.e., what is additionally required to complete the project). The applicants are strongly encouraged to give us additional information including references or other materials to facilitate the evaluation process.

 

Privacy, confidentiality & FAQ
The Company
The Company will not share the information beyond its own staff; your initial proposal should contain only non-confidential information. If your proposal is selected, the Company is open to complete a Confidentiality Disclosure Agreement (CDA).

Biowebspin
Biowebspin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data. Biowebspin is a matchmaking platform between academia & industry. Biowebspin is not involved in the IP discussion and is not charging any success or license fees. Your «Open Innovation» proposal on Biowebspin are only visible by industrials and the Biowebspin team. You can remove your data at any time. Biowebspin strongly recommends that you do not enter any confidential data or if you do so, that your technology transfer office agrees the submission of your pre-proposal on Biowebspin. If you directly submit your pre-proposal on an industrial partner website, you will agree their terms, conditions and privacy policy of our industrial partner website. Biowebspin is not responsible for the content, accuracy, or opinion of its industrial partner website. As a Swiss International company, Biowebspin has high standard security and privacy system. Biowebspin is in accordance with the Federal Data Protection and Information Commissioner. Contact us for more information about the terms and conditions of the matchmaking service of Biowebspin.

About Biowebspin:

Biowebspin is the #1 academia-industry partnering network in Life Sciences.
For academics, Biowebspin is the platform to find industrial partners and funding for their research projects matching R&D programs of more than 500 leading Life Sciences companies and foundations.

Check if one program will fit your researches for industrial collaboration and funding